Geno Pharmaceuticals Private Limited, a active private limited company, was established on 04 December 1975 in Goa, Goa, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GA1975PTC000250. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹3.00 Cr.
Formerly known as Geno Pharmaceuticals Limited. It upholds a compliant status. Employing 1,181 professional, Its leadership includes Dilip Salgaocar Ramacrisna (Director), Sagar Dilip Salgaocar (Managing Director), Pramod Dilip Salgaocar (Whole-Time Director). Past directors included Dilip Salgaocar Ramacrisna, Sagar Dilip Salgaocar, Pramod Dilip Salgaocar. It holds ₹136.64 Cr open charges and ₹96.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Tivim Industrial Estatekasarwada Mapusa, Goa, Goa.
U24239GA1975PTC000250
000250
04 December 1975
₹6.50 Cr
₹3.00 Cr
Roc Goa
Unlisted
Active
Explore comprehensive insights into Geno Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilip Salgaocar Ramacrisna | Director | 01 Jan 1980 | Current |
| Sagar Dilip Salgaocar | Managing Director | 01 Oct 2010 | Current |
| Pramod Dilip Salgaocar | Whole-Time Director | 30 Sep 2006 | Current |
| Shivam Sagar Salgaocar | Director | 23 Oct 2023 | Current |
| Pallavi Sagar Salgaocar | Whole-Time Director | 30 Sep 2004 | Current |
| Suriakiran Umacanta Sinaikunde | Director | 25 Oct 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 14 Nov 2021 | Past |
| Pramod Abcsdd | Director | 01 Oct 2016 | Past |
| Pramod Abcsdd | Director | 01 Oct 2006 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 25 Oct 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Geno Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.5% increase. The company also saw a slight decrease in profitability, with a 9.25% decrease in profit. The company's net worth moved up by a moderate rise of 7.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Geno Pharmaceuticals had a promoter holding of 89.92% and a public holding of 10.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,366,373,870.00
₹969,534,353.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2025 | Hdfc Bank Limited | ₹4.39 Cr | Open |
| 01 Sep 2025 | Hdfc Bank Limited | ₹85.00 Cr | Open |
| 11 Mar 2022 | State Bank Of India | ₹4.23 Cr | Open |
| 26 Dec 2013 | Canara Bank | ₹43.00 Cr | Open |
| 18 Nov 1983 | Mapusa Urban Co-Operation Ltd. | ₹0.20 M | Open |
Explore comprehensive loan charge details -
Geno Pharmaceuticals has a workforce of 1181 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Geno Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geno Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 4.39 Cr with Charge ID 101165122 was registered on 25 Sep 2025. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 85.00 Cr registered on 01 Sep 2025 with Charge ID 101147312 was modified on 08 Sep 2025. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 85.00 Cr with Charge ID 101147312 was registered on 01 Sep 2025. was completed.
A charge with Canara Bank of Rs. 43.00 Cr registered on 26 Dec 2013 with Charge ID 10470582 was modified on 29 May 2025. was recorded as a recent event.
Progress on A charge registered on 09 Mar 2022 via Charge ID 100554721 with Others was fully satisfied on 16 Apr 2025. was documented.
The activity Geno Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The CIN of Geno Pharmaceuticals Private Limited is U24239GA1975PTC000250.
Geno Pharmaceuticals Private Limited is headquartered at Tivim Industrial Estatekasarwada Mapusa, Goa, Goa.
Geno Pharmaceuticals Private Limited was incorporated on 04 December 1975.
The current directors of Geno Pharmaceuticals Private Limited are
The primary industry of Geno Pharmaceuticals Private Limited is Manufacturing.
Geno Pharmaceuticals Private Limited is unlisted.
The authorized capital of Geno Pharmaceuticals Private Limited is ₹6.50 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Geno Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX